Health Care/Hospital

Nanoform raises its mid-term business targets for 2025

HELSINKI, June 2, 2021 /PRNewswire/ -- Nanoform Finland Plc ("Nanoform"), an innovative nanoparticle medicine enabling company, today announced its raised mid-term business targets for 2025. The new targets are as follows:            * To nanoform annually at least 70 new active pharmaceutical ...

2021-06-02 21:42 1422

GenScript Biotech and Ligand Pharmaceuticals Enter into Global OmniAb® Licensing Agreement

NANJING, China and SAN DIEGO, June 2, 2021 /PRNewswire/ -- GenScript Biotech Corporation (HKG: 1548) along with its subsidiary, GenScript ProBio, and Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) announced today that they have entered into a strategic licensing agreement for Ligand's OmniAb®...

2021-06-02 21:00 8690

Portonbio announced strategic cooperation with KAEDI to accelerate the R&D and production of CAR-T drugs

SUZHOU, China, June 2, 2021 /PRNewswire/ -- On May 31, 2021, Porton Biologics Ltd. (hereinafter referred to as Portonbio) announced a strategic cooperation with Nanjing KAEDI Biotech, Inc. (hereinafter referred to as KAEDI).Portonbio will offer CMC services for KAEDI's CAR-T cell therapies with i...

2021-06-02 20:10 1422

Shanghai Asclepius Meditec and International Department of Central Committee of CPC Collaborate to Provide Emergency Support to Fight COVID-19 in Nepal

SHANGHAI, June 2, 2021 /PRNewswire/ -- The President of Asclepius Meditec – the company behind the innovativeHydrogen Oxygen Generator with Nebulizer

2021-06-02 20:00 1399

PharmAbcine to Present at the BIO Digital International Convention 2021

DAEJEON, South Korea, June 2, 2021 /PRNewswire/ -- PharmAbcine Inc. (KOSDAQ: 208340ks), a clinical-stage biotech company focusing on the development of antibody therapeutics, announced today that the company will participate in BIO Digital International Convention. The company will participate in...

2021-06-02 20:00 2119

Mindray Launches Resona I9 Ultrasound System, Revolutionizing General Imaging

SHENZHEN, China, June 2, 2021 /PRNewswire/ -- Mindray (SZSE: 300760), a global leading developer and provider of medical devices and solutions, has announced the release of its latest general imaging diagnostic ultrasound system,Resona I9 , to it...

2021-06-02 19:04 6250

Samsung Biologics and KAHR Medical Announce Development and Manufacturing Agreement for Cancer Immunotherapy Drug Candidate

INCHEON, South Korea, June 2, 2021 /PRNewswire/ -- Samsung Biologics (KRX: 207940.KS), the world's leading contract development and manufacturing organization, signed a strategic partnership with KAHR Medical Ltd., a cancer immunotherapy company developing novel multifunctional immune-recruitment...

2021-06-02 19:00 1177

Menopause to Become the Next Game-changer in the Global Femtech Solutions Industry by 2025

SANTA CLARA, Calif., June 2, 2021 /PRNewswire/ -- Frost & Sullivan's recent analysis on theglobal femtech solutions industry finds that the COVID-19 pandemic has led to a dramatic rise in women's physical and mental health issues. While digital health solutions, now under the broader term of virt...

2021-06-02 18:03 1226

Betagenon AB announces investment and collaboration with Hong Kong-based MCG Technology Group Ltd

STOCKHOLM, June 2, 2021 /PRNewswire/ -- Betagenon AB, a Sweden-based biotech company focused on development of AMPK activator compounds, and MCG Technology Group Ltd, aHong Kong-based biotech investment group, today announced that MCG Technology Group will invest in and collaborate with Betagenon...

2021-06-02 16:23 1275

ImmVira will present the U.S. Clinical Phase I Study Results of MVR-T3011 via Intratumoral Administration at ASCO 2021

SHENZHEN, China, June 2, 2021 /PRNewswire/ -- ImmVira will present results from its clinical Phase I study of MVR-T3011 via intratumoral (IT) administration at the 2021 American Society of Clinical Oncology (ASCO) Annual Meeting on June 4- 8, 2021 for the first time.

2021-06-02 16:14 1103

Therabody™ Announces Partnership With World-Renowned Footballer Cristiano Ronaldo

The Company Releases its Largest Global Ad Campaign since its Founding to Amplify the Importance of Recovery LOS ANGELES, June 2, 2021 /PRNewswire/ -- Therabody, the global leader in tech wellness and the creators of theTheragun®, announced today professional footballerCristiano Ronaldo as the c...

2021-06-02 15:00 1927

Therabody™ Announces Partnership With World-Renowned Footballer Cristiano Ronaldo

LOS ANGELES, June 2, 2021 /PRNewswire/ -- Therabody, the global leader in tech wellness and the creators of theTheragun®, announced today professional footballerCristiano Ronaldo as the company's newest Therabody Athlete. The partnership also marks the release of Therabody's largest global ad cam...

2021-06-02 15:00 1504

Cigna International survey finds perception of safety and acceptance of COVID-19 vaccines improving

Key research findings: * Vaccine rollout progressing well - 25% of our sample of over 13,000 people are now vaccinated * Overall vaccine acceptance up from 63% to 66%, and 60% of people believe vaccines will be readily available to them, up 2% * Notable differences between markets, particul...

2021-06-02 11:36 12667

Antengene Announces Abstracts on Twelve Clinical Studies of Selinexor Selected by EHA 2021

SHANGHAI and HONG KONG, June 2, 2021 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative biopharmaceutical company dedicated to discovering, developing and commercializing global first-in-class and/or best-in-class therapeutics in hematology and oncolo...

2021-06-02 08:00 2747

Transcenta Announced Completion of First Patient Dosing in PET-CT Imaging Study of Radionuclide-Labeled CLDN18.2 Antibody

SUZHOU, China, June 2, 2021 /PRNewswire/ -- Transcenta Holding Limited ("Transcenta"), a global biotherapeutics company with fully-integrated capabilities in discovery, development and manufacturing of antibody-based therapeutics, announced completion of first patient dosing in PET-CT imaging st...

2021-06-02 08:00 1869

Antengene Announces Fifteen Clinical Studies and Results of Selinexor to be Presented at ASCO 2021

SHANGHAI and HONG KONG, June 2, 2021 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative biopharmaceutical company dedicated to discovering, developing and commercializing global first-in-class and/or best-in-class therapeutics in hematology and oncolo...

2021-06-02 08:00 2387

Bridge Biotherapeutics Announces the Initiation of the Proof of Mechanism Study for BBT-401 in Patients with Ulcerative Colitis; Rectal Delivery of Drug to Target Site

* The new proof of mechanism trial in ulcerative colitis had its first patient dosed inNew Zealand * In parallel with the oral-administered, proof of clinical principle study, the new proof of mechanism study will examine the efficacy of BBT-401 when delivered directly to the target organ via...

2021-06-02 06:00 1374

Eucure Biopharma to Present Findings From Anti-CD40 and Anti-CTLA-4 mAb Clinical Trials at the 2021 ASCO Meeting

BEIJING and BOSTON, June 1, 2021 /PRNewswire/ -- Eucure Biopharma will present findings from two Phase I clinical trials at the 2021 American Society of Clinical Oncology (ASCO) Annual Meeting, held fromJune 4th to 8th. The first trial (poster #2580; NCT04481009) is designed to assess the safety...

2021-06-02 01:28 1375

New 3M™ Harvest RC clarifier brings chromatography technology to harvest clarification with a single-stage solution for upstream processes

ST. PAUL, Minn., June 2, 2021 /PRNewswire/ -- 3M Health Care launched 3M™ Harvest RC clarifier, leveraging its proprietary fibrous chromatography media to deliver a single-stage purification solution for recombinant protein therapeutic manufacturing. It is the next generation in harvest and clar...

2021-06-02 01:00 5393

Puyi Biotechnology Completes Series B Financing

SHANGHAI, June 1, 2021 /PRNewswire/ -- Puyi (Shanghai) Biotechnology Co., Ltd. ("Puyi Biotechnology") recently announced the completion of its Series B financing led by Goldman Sachs Asset Management. The proceeds will be used to further augment R&D and business development. Puyi Biotechnology i...

2021-06-01 22:32 2336
1 ... 510511512513514515516 ... 810